Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 161
YÖKSİS161 OpenAlex0
Projects 0
Books 0
Proceedings 10

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 147
h-index 19 Percentile in Türkiye: 97 #11 of 1,071 at their university by h-index
i10-index
32
Total citations
16,120
Top 0.1% in Türkiye
Per article
109.7
FWCI
6.46
1.00 = world average
World top 1%
7
World top 10%
12

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 157
  • Q1 88 %56.1
  • Q2 44 %28.0
  • Q3 23 %14.6
  • Q4 2 %1.3
WoS (JCR) 159
  • Q1 56 %35.2
  • Q2 28 %17.6
  • Q3 27 %17.0
  • Q4 48 %30.2
TR Index 4 articles
OpenAlex citation percentile
Top 1%7
Top 10%12
Avg · n 138 %48.1
Other counts

Scopus (SJR)

  • YÖKSİS rows 163

WoS (JCR)

  • YÖKSİS rows 165

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

161articles

Journals with publications

64 journals

Narrow down

Scopus (SJR)
WoS (JCR)
TR Index

Article filter applied. Journal filter: Experimental and Clinical Transplantation Clear filter ×

Article list

10 / 161 articles

  1. 2025 Posttransplant Malignancies in Adult Transplant Patients EXPERIMENTAL AND CLINICAL TRANSPLANTATION DOI 10.6002/ect.2025.0081 YÖKSİS SJR Q3 JCR Q4
  2. 2025 Recurrence of Hepatocellular Carcinoma After Liver Transplant: A Single-Center Experience EXPERIMENTAL AND CLINICAL TRANSPLANTATION DOI 10.6002/ect.2025.0041 YÖKSİS SJR Q3 JCR Q4
  3. 2022 Recent Advances in Systemic Therapy for Hepatocellular Carcinoma Experimental and Clinical Transplantation DOI 10.6002/ect.2021.0478 YÖKSİS SJR Q3 JCR Q4
  4. 2022 Solid-Organ Transplantation From Deceased and Living Donors With Cancer or a History of Cancer Experimental and Clinical Transplantation DOI 10.6002/ect.DonorSymp.2022.L30 YÖKSİS SJR Q3 JCR Q4 OpenAlex 59.2%
  5. 2020 Vismodegib Experience in a Renal Transplant Patient With Basal Cell Carcinoma Experimental and Clinical Transplantation DOI 10.6002/ect.2019.0293 YÖKSİS SJR Q3 JCR Q4 OpenAlex 50.9%
  6. 2020 Single-Center Experience of Recurrence Patterns and Survival Analyses of Patients With Hepatocellular Carcinoma and Liver Transplant Experimental and Clinical Transplantation DOI 10.6002/ect.2020.0046 YÖKSİS SJR Q3 JCR Q4 OpenAlex 54.8%
  7. 2018 Posttransplant Malignancies in Adult Renal and Hepatic Transplant Patients Experimental and Clinical Transplantation DOI 10.6002/ect.2018.0177 YÖKSİS SJR Q3 JCR Q4 OpenAlex 8.6%
  8. 2014 Posttransplant malignancies in liver transplant recipients Experimental and Clinical Transplantation YÖKSİS SJR Q3 JCR Q4
  9. 2014 Posttransplant Malignancies in Liver Transplant Recipients Experimental and Clinical Transplantation DOI 10.6002/ect.25Liver.P42 YÖKSİS SJR Q3 JCR Q4
  10. 2014 Posttransplant malignancies in liver transplant recipients. Experimental and Clinical Transplantation YÖKSİS SJR Q3 JCR Q4

← Back to academicians